MetaTOC stay on top of your field, easily

Safety of cyclophosphamide infusion time modification from 60 to 30 minutes in selected chemotherapy regimens for lymphoma and multiple myeloma

, ,

Journal of Oncology Pharmacy Practice

Published online on

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundShortening chemotherapy infusion times is associated with improvements in resource use and patient satisfaction, as well as reductions in nursing workload and clinic wait times. Cyclophosphamide package inserts mention that the drug should be ...